Home » Topics » Deals and M&A » Collaboration

Collaboration
RSS

Optimer Pharma and Astellas enter agreement for antibiotic fidaxomicin

Feb. 8, 2011

Phosphagenics enters agreement to develop TPM-delivered antipsoriasis drug

Feb. 8, 2011

Progenics and Salix Pharma enter into license agreement for Relistor

Feb. 8, 2011

Lilly and JDRF to study beta-cell regeneration to treat type 1 diabetes

Feb. 7, 2011

Tacere Therapeutics achieves milestone under collaboration with Pfizer

Feb. 7, 2011

Galapagos and Merck & Co. agree to end strategic alliances

Feb. 7, 2011

Pfizer and Takeda sign copromotion agreements for rheumatoid arthritis products

Feb. 4, 2011

Apeiron acquires rights to hu14.18-IL2 from Merck KGaA

Feb. 4, 2011

Theratechnologies and Ferrer enter into agreement for tesamorelin in Europe

Feb. 4, 2011

Marina Biotech and Debiopharm partner for RNAi-based bladder cancer therapy

Feb. 4, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 1, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
New evidence links autoimmunity to long COVID symptoms
BioWorld
Recent findings are reshaping current understanding of the post-infection landscape of SARS-CoV-2. Although previous studies had already suggested that...
BMS’ mezigdomide doubles PFS in multiple myeloma
BioWorld
Bristol Myers Squibb Co. disclosed in March 2026 that the phase III portion of the seamless phase II/III Successor-2 study testing mezigdomide in combination with...
Breakthrough as GSK’s bepirovirsen clears 19% of chronic hep B infections
BioWorld
GSK plc has announced a breakthrough in the treatment of chronic hepatitis B, reporting a functional cure rate of 19% across two phase III trials of its antisense...